Jpmorgan Chase & CO Immunovant, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Immunovant, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 228,257 shares of IMVT stock, worth $6.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
228,257
Previous 256,843 11.13%
Holding current value
$6.28 Million
Previous $6.78 Million 7.39%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$27.51 - $27.51 $786,400 - $786,400
-28,586 Reduced 11.13%
228,257 $6.28 Million
Q3 2024

Nov 08, 2024
SELL
$27.51 - $27.51 $786,400 - $786,400
-28,586 Reduced 11.13%
228,257 $6.28 Million
Q2 2024

Dec 26, 2024
BUY
$25.1 - $31.61 $717,508 - $903,603
28,586 Added 12.52%
256,843 $6.78 Million
Q2 2024

Aug 12, 2024
BUY
$25.1 - $31.61 $296,431 - $373,314
11,810 Added 4.82%
256,843 $6.78 Million
Q1 2024

Dec 26, 2024
BUY
$30.27 - $43.79 $507,809 - $734,621
16,776 Added 7.35%
245,033 $7.92 Million
Q1 2024

May 10, 2024
SELL
$30.27 - $43.79 $6.84 Million - $9.89 Million
-225,957 Reduced 47.97%
245,033 $7.92 Million
Q4 2023

Dec 26, 2024
BUY
$31.31 - $44.19 $7.6 Million - $10.7 Million
242,733 Added 106.34%
470,990 $19.8 Million
Q4 2023

Feb 12, 2024
BUY
$31.31 - $44.19 $1.33 Million - $1.88 Million
42,482 Added 9.91%
470,990 $19.8 Million
Q3 2023

Nov 14, 2023
SELL
$18.55 - $39.96 $259,718 - $559,479
-14,001 Reduced 3.16%
428,508 $16.5 Million
Q2 2023

Aug 11, 2023
BUY
$14.2 - $23.75 $5.4 Million - $9.04 Million
380,517 Added 613.82%
442,509 $8.39 Million
Q1 2023

May 18, 2023
BUY
$15.27 - $19.72 $938,830 - $1.21 Million
61,482 Added 12055.29%
61,992 $961,000
Q1 2023

May 11, 2023
SELL
$15.27 - $19.72 $762,034 - $984,106
-49,904 Reduced 98.99%
510 $7,000
Q4 2022

Feb 13, 2023
SELL
$6.59 - $17.75 $743,312 - $2 Million
-112,794 Reduced 69.11%
50,414 $895,000
Q3 2022

Nov 14, 2022
SELL
$3.93 - $6.37 $1.93 Million - $3.12 Million
-489,973 Reduced 75.01%
163,208 $911,000
Q2 2022

Aug 11, 2022
BUY
$3.38 - $5.65 $647,604 - $1.08 Million
191,599 Added 41.51%
653,181 $2.55 Million
Q1 2022

May 11, 2022
BUY
$5.06 - $8.77 $1.57 Million - $2.72 Million
310,520 Added 205.56%
461,582 $2.54 Million
Q4 2021

Feb 10, 2022
SELL
$7.33 - $9.32 $1.52 Million - $1.94 Million
-207,731 Reduced 57.9%
151,062 $1.29 Million
Q3 2021

Nov 12, 2021
BUY
$7.01 - $11.37 $2.52 Million - $4.08 Million
358,793 New
358,793 $3.12 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email